The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis
Open accessAbstract
Epigenetic modifications, including changes in DNA methylation, lead to altered gene expression and thus may underlie epileptogenesis via induction of permanent changes in neuronal excitability. Therapies that could inhibit or reverse these changes may be highly effective in halting disease progression. Here we identify an epigenetic function of the brain's endogenous anticonvulsant adenosine, showing that this compound induces hypomethylation of DNA via biochemical interference with the transmethylation pathway. We show that inhibition of DNA methylation inhibited epileptogenesis in multiple seizure models. Using a rat model of temporal lobe epilepsy, we identified an increase in hippocampal DNA methylation, which correlates with increased DNA methyltransferase activity, disruption of adenosine homeostasis, and spontaneous recurrent seizures. Finally, we used bioengineered silk implants to deliver a defined dose of adenosine over 10 days to the brains of epileptic rats. This transient therapeutic intervention reversed the DNA hypermethylation seen in the epileptic brain, inhibited sprouting of mossy fibers in the hippocampus, and prevented the progression of epilepsy for at least 3 months. These data demonstrate that pathological changes in DNA methylation homeostasis may underlie epileptogenesis and reversal of these epigenetic changes with adenosine augmentation therapy may halt disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MethPrimer: designing primers for methylation PCRs
Li, L.-C., & Dahiya, R. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.11.1427 · Cited by 2,729
Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons
Feng, J., Zhou, Y., Campbell, S. L., Le, T., Li, E., Sweatt, J. D., Silva, A. J., & Fan, G. (2010) · Nature Neuroscience · doi:10.1038/nn.2514 · Cited by 1,019
Neuronal Activity–Induced Gadd45b Promotes Epigenetic DNA Demethylation and Adult Neurogenesis
Ma, D. K., Jang, M.-H., Guo, J. U., Kitabatake, Y., Chang, M.-L., Pow-anpongkul, N., Flavell, R. A., Lu, B., Ming, G.-L., & Song, H. (2009) · Science · doi:10.1126/science.1166859 · Cited by 924
de Tisi, J., Bell, G. S., Peacock, J. L., McEvoy, A. W., Harkness, W. F., Sander, J. W., & Duncan, J. S. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60890-8 · Cited by 887
The equilibrative nucleoside transporter family, SLC29
Beal, P. R., Yao, S. Y. M., Baldwin, S. A., Young, J. D., King, A. E., & Cass, C. E. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1103-2 · Cited by 710
Tsai, H.-C., Li, H., Van Neste, L., Cai, Y., Robert, C., Rassool, F. V., Shin, J. J., Harbom, K. M., Beaty, R., Pappou, E., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.029 · Cited by 650
Mechanisms of epileptogenesis and potential treatment targets
Pitkänen, A., & Lukasiuk, K. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70310-0 · Cited by 614
Cavazos, J., Golarai, G., & Sutula, T. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-09-02795.1991 · Cited by 535
Johansson, B., Halldner, L., Dunwiddie, T. V., Masino, S. A., Poelchen, W., Giménez-Llort, L., Escorihuela, R. M., Fernández-Teruel, A., Wiesenfeld-Hallin, Z., Xu, X.-J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161292398 · Cited by 505
The concentrative nucleoside transporter family, SLC28
Gray, J. H., Owen, R. P., & Giacomini, K. M. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1107-y · Cited by 419
Löscher, W., & Brandt, C. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003046 · Cited by 414
James, S. J., Melnyk, S., Pogribna, M., Pogribny, I. P., & Caudill, M. A. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.8.2361s · Cited by 367
Adenosine Kinase: Exploitation for Therapeutic Gain
Boison, D. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006361 · Cited by 310
Self-citationA ketogenic diet suppresses seizures in mice through adenosine A1 receptors
Masino, S. A., Li, T., Theofilas, P., Sandau, U. S., Ruskin, D. N., Fredholm, B. B., Geiger, J. D., Aronica, E., & Boison, D. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57813 · Cited by 308
Self-citationAdenosine signaling and function in glial cells
Boison, D., Chen, J.-F., & Fredholm, B. B. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.131 · Cited by 306
Self-citationEpileptogenesis in the dentate gyrus: a critical perspective
Dudek, F. E., & Sutula, T. P. (2007) · Progress in Brain Research · doi:10.1016/s0079-6123(07)63041-6 · Cited by 301
Lovatt, D., Xu, Q., Liu, W., Takano, T., Smith, N. A., Schnermann, J., Tieu, K., & Nedergaard, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120997109 · Cited by 273
Nelson, E. D., Kavalali, E. T., & Monteggia, L. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3796-07.2008 · Cited by 254
Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice
Li, T., Ren, G., Lusardi, T., Wilz, A., Lan, J. Q., Iwasato, T., Itohara, S., Simon, R. P., & Boison, D. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33737 · Cited by 250
Self-citationAdenosine kinase, epilepsy and stroke: mechanisms and therapies
Boison, D. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.10.008 · Cited by 241
Self-citationCsoka, A. B., & Szyf, M. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.10.039 · Cited by 241
Neonatal hepatic steatosis by disruption of the adenosine kinase gene
Boison, D., Scheurer, L., Zumsteg, V., Rülicke, T., Litynski, P., Fowler, B., Brandner, S., & Mohler, H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092642899 · Cited by 225
Self-citationThe adenosine kinase hypothesis of epileptogenesis
Boison, D. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.12.002 · Cited by 225
Self-citationOverexpression of Adenosine Kinase in Epileptic Hippocampus Contributes to Epileptogenesis
Gouder, N., Scheurer, L., Fritschy, J.-M., & Boison, D. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4781-03.2004 · Cited by 223
Self-citationGouder, N., Fritschy, J., & Boison, D. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.03603.x · Cited by 207
Self-citationGrafts of adenosine-releasing cells suppress seizures in kindling epilepsy
Huber, A., Padrun, V., Déglon, N., Aebischer, P., Möhler, H., & Boison, D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131102898 · Cited by 205
Self-citationFedele, D. E., Gouder, N., Güttinger, M., Gabernet, L., Scheurer, L., Rülicke, T., Crestani, F., & Boison, D. (2005) · Brain · doi:10.1093/brain/awh555 · Cited by 192
Self-citationKobow, K., Jeske, I., Hildebrandt, M., Hauke, J., Hahnen, E., Buslei, R., Buchfelder, M., Weigel, D., Stefan, H., Kasper, B., et al. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31819ba737 · Cited by 178
Studer, F. E., Fedele, D. E., Marowsky, A., Schwerdel, C., Wernli, K., Vogt, K., Fritschy, J. M., & Boison, D. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.06.016 · Cited by 168
Self-citationUpregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy
Aronica, E., Zurolo, E., Iyer, A. M., de Groot, M., Anink, J. J., Carbonell, C., van Vliet, E. A., Baayen, J. C., Boison, D., & Gorter, J. A. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03115.x · Cited by 154
Self-citationSilk polymer-based adenosine release: Therapeutic potential for epilepsy
Wilz, A., Pritchard, E. M., Li, T., Lan, J., Kaplan, D. L., & Boison, D. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.05.010 · Cited by 135
Self-citationADP-ribose polymers localized on Ctcf–Parp1–Dnmt1 complex prevent methylation of Ctcf target sites
Zampieri, M., Guastafierro, T., Calabrese, R., Ciccarone, F., Bacalini, M. G., Reale, A., Perilli, M., Passananti, C., & Caiafa, P. (2011) · Biochemical Journal · doi:10.1042/bj20111417 · Cited by 130
The methylation hypothesis: Do epigenetic chromatin modifications play a role in epileptogenesis?
Kobow, K., & Blümcke, I. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03145.x · Cited by 126
Rebola, N., Coelho, J. E., Costenla, A. R., Lopes, L. V., Parada, A., Oliveira, C. R., Soares-da-Silva, P., de Mendonça, A., & Cunha, R. A. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02815.x · Cited by 122
Antiepileptic effects of silk-polymer based adenosine release in kindled rats
Szybala, C., Pritchard, E. M., Lusardi, T. A., Li, T., Wilz, A., Kaplan, D. L., & Boison, D. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.05.018 · Cited by 113
Self-citationEpigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis
Qureshi, I. A., & Mehler, M. F. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.02.005 · Cited by 112
Adenosine augmentation therapies (AATs) for epilepsy: Prospect of cell and gene therapies
Boison, D. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.03.019 · Cited by 99
Self-citationDudek, F. E., & Staley, K. J. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.03.071 · Cited by 95
Pignataro, G., Maysami, S., Studer, F. E., Wilz, A., Simon, R. P., & Boison, D. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600499 · Cited by 84
Self-citationAdenosine as a Modulator of Brain Activity
Boison, D. (2007) · Drug News & Perspectives · doi:10.1358/dnp.2007.20.10.1181353 · Cited by 82
Self-citationCui, X. A., Singh, B., Park, J., & Gupta, R. S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.106 · Cited by 66
Epileptogenesis: Can the Science of Epigenetics Give Us Answers?
Lubin, F. D. (2012) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7511-12.3.105 · Cited by 45
Rethinking the purinergic neuron–glia connection
Fredholm, B. B. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203764109 · Cited by 15
Cited by
Thijs, R. D., Surges, R., O'Brien, T. J., & Sander, J. W. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32596-0 · Cited by 2,183
Devinsky, O., Vezzani, A., O'Brien, T. J., Jette, N., Scheffer, I. E., de Curtis, M., & Perucca, P. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.24 · Cited by 959
Pharmacology of Adenosine Receptors: The State of the Art
Borea, P. A., Gessi, S., Merighi, S., Vincenzi, F., & Varani, K. (2018) · Physiological Reviews · doi:10.1152/physrev.00049.2017 · Cited by 783
The adenosine pathway in immuno-oncology
Allard, B., Allard, D., Buisseret, L., & Stagg, J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0382-2 · Cited by 586
How does adenosine control neuronal dysfunction and neurodegeneration?
Cunha, R. A. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13724 · Cited by 441
Metadata
- Authors
- Williams-Karnesky, R. L., Sandau, U. S., Lusardi, T. A., Lytle, N. K., Farrell, J. M., Pritchard, E. M., Kaplan, D. L., & Boison, D.
- Venue
- Journal of Clinical Investigation
- Published
- 2013-07-25
- Volume
- 123
- Issue
- 8
- Pages
- 3552-3563
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1982903836
- Cited by
- 266
- References
- 43
- FWCI
- 10.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.